Alectinib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150 mg

Reference Brands: Alecensa (USA/EU)

Category: Oncology Cancer Care

Alectinib is an oral anticancer medication used for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It works as a tyrosine kinase inhibitor (TKI) that specifically targets and blocks the activity of the anaplastic lymphoma kinase (ALK) protein, which promotes the growth of cancer cells. By inhibiting ALK, alectinib helps slow or stop the spread of cancer. Alectinib is available in Capsules and strengths such as 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Alectinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Alectinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.